Richard Matt, Principal Consultant at Aspen Medical Risk Consulting, leads a breakout session on achieving post-market excellence through evolved vigilance practices. As regulatory expectations for post-market surveillance continue to intensify, safety organizations must transform their approaches to adverse event detection, signal management, and benefit-risk assessment.
Richard will present a maturity model for post-market vigilance that helps organizations benchmark their current capabilities and identify priority areas for improvement. The session will cover advanced signal detection methodologies, the integration of real-world data sources into safety monitoring, and strategies for building a continuous improvement culture within safety teams.
This session is designed for safety and quality professionals who want to move beyond minimum compliance and build post-market capabilities that create genuine competitive advantage.
Track
Drug safety, pharmacovigilance, regulatory compliance
Aparna Ahuja
Mike Xie, Subhadip Jana
Leo Park
Edward Chekan, Humberto Valbuena